255 related articles for article (PubMed ID: 20484595)
1. Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells.
Skeie JM; Fingert JH; Russell SR; Stone EM; Mullins RF
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5336-42. PubMed ID: 20484595
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
3. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
Liu L; Zhang Y; Duan X; Peng Q; Liu Q; Zhou Y; Quan S; Xing G
J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
[TBL] [Abstract][Full Text] [Related]
4. Drusen complement components C3a and C5a promote choroidal neovascularization.
Nozaki M; Raisler BJ; Sakurai E; Sarma JV; Barnum SR; Lambris JD; Chen Y; Zhang K; Ambati BK; Baffi JZ; Ambati J
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2328-33. PubMed ID: 16452172
[TBL] [Abstract][Full Text] [Related]
5. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
Rohrer B
Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
[TBL] [Abstract][Full Text] [Related]
6. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
[TBL] [Abstract][Full Text] [Related]
7. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
8. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
Cravedi P; Leventhal J; Lakhani P; Ward SC; Donovan MJ; Heeger PS
Am J Transplant; 2013 Oct; 13(10):2530-9. PubMed ID: 24033923
[TBL] [Abstract][Full Text] [Related]
9. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
10. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
11. CFH Y402H polymorphism is associated with elevated vitreal GM-CSF and choroidal macrophages in the postmortem human eye.
Wang JC; Cao S; Wang A; To E; Law G; Gao J; Zhang D; Cui JZ; Matsubara JA
Mol Vis; 2015; 21():264-72. PubMed ID: 25814824
[TBL] [Abstract][Full Text] [Related]
12. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
13. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
14. Complement c3a and c5a induce different signal transduction cascades in endothelial cells.
Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R
J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538
[TBL] [Abstract][Full Text] [Related]
15. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
17. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina.
Mullins RF; Skeie JM; Malone EA; Kuehn MH
Mol Vis; 2006 Mar; 12():224-35. PubMed ID: 16604055
[TBL] [Abstract][Full Text] [Related]
18. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells.
Foreman KE; Glovsky MM; Warner RL; Horvath SJ; Ward PA
Inflammation; 1996 Feb; 20(1):1-9. PubMed ID: 8926043
[TBL] [Abstract][Full Text] [Related]
19. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
20. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]